Metabolic syndrome, type II diabetes and atherosclerosis congress
3rd Metabolic Syndrome, type II Diabetes and Atherosclerosis Meeting
Organizing Committee and Scientific Advisory Board
abstract submission MSDA 2006...
all scientific sessions...
Marrakesh May 24th to May 28th...
Chartered flight...
Congress Opening Ceremony
to receive your invitation for MSDA 2006...
Organizing Secreteriat and Congress Venue
 
PROGRAM
THURSDAY, MAY 25, 2006
03.30 p.m. – 04.00 p.m.
COFFEE BREAK
sapcer
04.00 p.m. – 05.30 p.m.
SYMPOSIUM SPONSORED BY KOWA   
Statins in the treatment of metabolic syndrome
Co-chair by: J. Betteridge (UK), Y. Matsuzawa (Japan)
 Adipocytokines and metabolic syndrome ...................................................................................... Y. Matsuzawa (Japan)
 Large cohort studies and -omic approaches to understanding,
 preventing and treating cardiovascular disease ............................................................................................ J. Scott (UK)
 The effect of pitavastatin on HDL metabolism ........................................................................................... N. Tada (Japan)
The use of statins in the management of CVD in diabetic patients .......................................................... J. Betteridge (UK)